34281248|t|Potential of Telomerase in Age-Related Macular Degeneration-Involvement of Senescence, DNA Damage Response and Autophagy and a Key Role of PGC-1alpha.
34281248|a|Age-related macular degeneration (AMD), the main cause of vision loss in the elderly, is associated with oxidation in the retina cells promoting telomere attrition. Activation of telomerase was reported to improve macular functions in AMD patients. The catalytic subunit of human telomerase (hTERT) may directly interact with proteins important for senescence, DNA damage response, and autophagy, which are impaired in AMD. hTERT interaction with mTORC1 (mTOR (mechanistic target of rapamycin) complex 1) and PINK1 (PTEN-induced kinase 1) activates macroautophagy and mitophagy, respectively, and removes cellular debris accumulated over AMD progression. Ectopic expression of telomerase in retinal pigment epithelium (RPE) cells lengthened telomeres, reduced senescence, and extended their lifespan. These effects provide evidence for the potential of telomerase in AMD therapy. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) may be involved in AMD pathogenesis through decreasing oxidative stress and senescence, regulation of vascular endothelial growth factor (VEGF), and improving autophagy. PGC-1alpha and TERT form an inhibitory positive feedback loop. In conclusion, telomerase activation and its ectopic expression in RPE cells, as well as controlled clinical trials on the effects of telomerase activation in AMD patients, are justified and should be assisted by PGC-1alpha modulators to increase the therapeutic potential of telomerase in AMD.
34281248	27	59	Age-Related Macular Degeneration	Disease	MESH:D008268
34281248	139	149	PGC-1alpha	Gene	10891
34281248	151	183	Age-related macular degeneration	Disease	MESH:D008268
34281248	185	188	AMD	Disease	MESH:D008268
34281248	209	220	vision loss	Disease	MESH:D014786
34281248	386	389	AMD	Disease	MESH:D008268
34281248	390	398	patients	Species	9606
34281248	425	430	human	Species	9606
34281248	570	573	AMD	Disease	MESH:D008268
34281248	606	610	mTOR	Gene	2475
34281248	660	665	PINK1	Gene	65018
34281248	667	688	PTEN-induced kinase 1	Gene	65018
34281248	789	792	AMD	Disease	MESH:D008268
34281248	842	868	retinal pigment epithelium	CellLine	CVCL:IQ82
34281248	870	873	RPE	CellLine	CVCL:IQ82
34281248	1018	1021	AMD	Disease	MESH:D008268
34281248	1031	1099	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	Gene	10891
34281248	1101	1111	PGC-1alpha	Gene	10891
34281248	1132	1135	AMD	Disease	MESH:D008268
34281248	1215	1249	vascular endothelial growth factor	Gene	7422
34281248	1251	1255	VEGF	Gene	7422
34281248	1283	1293	PGC-1alpha	Gene	10891
34281248	1298	1302	TERT	Gene	7015
34281248	1413	1416	RPE	CellLine	CVCL:IQ82
34281248	1505	1508	AMD	Disease	MESH:D008268
34281248	1509	1517	patients	Species	9606
34281248	1559	1569	PGC-1alpha	Gene	10891
34281248	1636	1639	AMD	Disease	MESH:D008268
34281248	Association	10891	7015
34281248	Association	MESH:D008268	7422
34281248	Association	MESH:D008268	10891
34281248	Association	MESH:D008268	65018
34281248	Association	10891	7422

